Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease
- PMID: 35339903
- PMCID: PMC8938917
- DOI: 10.1016/j.virol.2022.03.003
Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease
Abstract
The challenge continues globally triggered by the absence of an approved antiviral drug against COVID-19 virus infection necessitating global concerted efforts of scientists. Nature still provides a renewable source for drugs used to solve many health problems. The aim of this work is to provide new candidates from natural origin to overcome COVID-19 pandemic. A virtual screening of the natural compounds database (47,645 compounds) using structure-based pharmacophore model and molecular docking simulations reported eight hits from natural origin against SARS-CoV-2 main proteinase (Mpro) enzyme. The successful candidates were of terpenoidal nature including taxusabietane, Isoadenolin A & C, Xerophilusin B, Excisanin H, Macrocalin B and ponicidin, phytoconstituents isolated from family Lamiaceae and sharing a common ent-kaurane nucleus, were found to be the most successful candidates. This study suggested that the diterpene nucleus has a clear positive contribution which can represent a new opportunity in the development of SARS-CoV-2 main protease inhibitors.
Keywords: COVID-19; Ent-kaurane; Main protease inhibitors; Pharmacophore; Terpenoids.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no competing interests.
Figures









Similar articles
-
A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.J Biomol Struct Dyn. 2022 Mar;40(5):2327-2338. doi: 10.1080/07391102.2020.1837680. Epub 2020 Oct 23. J Biomol Struct Dyn. 2022. PMID: 33094680 Free PMC article.
-
Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.J Biomol Struct Dyn. 2021 Oct;39(16):6171-6183. doi: 10.1080/07391102.2020.1801510. Epub 2020 Aug 3. J Biomol Struct Dyn. 2021. PMID: 32741312
-
Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study.Molecules. 2020 Aug 17;25(16):3745. doi: 10.3390/molecules25163745. Molecules. 2020. PMID: 32824454 Free PMC article.
-
Advances in the Development of SARS-CoV-2 Mpro Inhibitors.Molecules. 2022 Apr 14;27(8):2523. doi: 10.3390/molecules27082523. Molecules. 2022. PMID: 35458721 Free PMC article. Review.
-
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease.Int J Mol Sci. 2022 Mar 23;23(7):3507. doi: 10.3390/ijms23073507. Int J Mol Sci. 2022. PMID: 35408866 Free PMC article. Review.
Cited by
-
In Silico Identification of New Anti-SARS-CoV-2 Main Protease (Mpro) Molecules with Pharmacokinetic Properties from Natural Sources Using Molecular Dynamics (MD) Simulations and Hierarchical Virtual Screening.J Trop Med. 2022 Oct 10;2022:3697498. doi: 10.1155/2022/3697498. eCollection 2022. J Trop Med. 2022. PMID: 36263438 Free PMC article.
-
Synthesis, optical properties, DNA, β-cyclodextrin interaction, hydrogen isotope sensor and computational study of new enantiopure isoxazolidine derivative (ISoXD).Heliyon. 2024 Feb 13;10(4):e26341. doi: 10.1016/j.heliyon.2024.e26341. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38404822 Free PMC article.
-
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MPro protein - an in silico and cell-based approach.Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z. Sci Rep. 2025. PMID: 40596019 Free PMC article.
References
-
- Abraham M.J., Murtola T., Schulz R., Páll S., Smith J.C., Hess B., Lindah E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. Software. 2015;1–2:19–25. doi: 10.1016/J.SOFTX.2015.06.001. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous